Your browser doesn't support javascript.
loading
FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology.
Li, Dan; Kusko, Rebecca; Ning, Baitang; Tong, Weida; Johann, Donald J; Xu, Joshua.
Afiliación
  • Li D; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
  • Kusko R; Immuneering Corporation, Cambridge, MA, USA.
  • Ning B; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
  • Tong W; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
  • Johann DJ; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Xu J; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
Precis Cancer Med ; 42021 Dec.
Article en En | MEDLINE | ID: mdl-35282311
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Precis Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Precis Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos